ACA
NVO

Affinity Capital Advisors’s Novo Nordisk NVO Stock Holding History

Affinity Capital Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$233K Buy
+4,725
New +$203K 0.03% 180

Other funds holding NVO

SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
VFM
Viking Fund Management Minot, North Dakota $1.12B AUM 44.65% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
ERP
Eldred Rock Partners San Antonio, Texas $465M AUM 48.86% 1-Year Est. Return
BIAS
Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

Affinity Capital Advisors's NVO Position: Q2 2026 in Review

Affinity Capital Advisors opened a new position in Novo Nordisk (NVO) in Q2 2026: 4,725 shares worth $233K. The stake represents 0.03% of the portfolio and ranks #180 among its holdings.

205 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Affinity Capital Advisors held 4,725 shares of Novo Nordisk worth $233K as of Q2 2026.
  • Novo Nordisk was a new Affinity Capital Advisors position in Q2 2026.
  • Novo Nordisk made up 0.03% of Affinity Capital Advisors's portfolio in Q2 2026, its #180 holding.
  • 205 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Affinity Capital Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.